克服生物可用性障碍:优化混合纳米载体系统通过皮耶补丁放大柏柏林吸收
Shubhangi A Thool1, Varsha B Pokharkar2
1Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune-411038, India.
AAPS PharmSciTech
|November 11, 2025
概括
这项研究开发了新的脂质聚合物混合纳米粒子 (BER-LPHN),以增强柏柏林.
科学领域:
- 药理学和纳米技术的应用
- 药物输送系统 药物输送系统
- 生物制药生物制药公司
背景情况:
- 柏柏林是一种异类类化合物,具有多种生物活性,但肠道吸收不良,限制了其治疗潜力.
- 提高贝贝林的口服生物可用性对于其有效的临床应用至关重要.
研究的目的:
- 开发和优化脂质聚合物混合纳米粒子 (BER-LPHN),以提高柏柏林的生物可用性.
- 调查BER-LPHN的配方,表征和体外/体内表现.
主要方法:
- 一种修改的纳米沉方法被用于制定BER-LPHN,优化3 ^ 2全因数设计.
- 纳米颗粒的表征包括大小,泽塔潜力,药物负载,形态 (TEM) 和体外药物释放.
- 在体内研究中使用光标记的纳米颗粒来评估肠道分布,皮耶尔贴片的吸收和淋巴运输.
主要成果:
- 优化的BER-LPHN显示了纳米大小 (250-350nm),负泽塔电位 (-25mV) 和高药物负载 (~87%).
- TEM揭示了具有脂质外和聚合物矩阵的球形纳米粒子,使控制释放和口服生物利用率增加了18倍.
- 在体内研究证实了小附近的纳米粒子度,佩耶尔贴片的显著吸收,以及通过M细胞的淋巴运输.
结论:
- 脂质聚合物混合纳米粒子有效地提高了柏柏林的口服生物可用性.
- 通过Peyer贴片的淋巴吸收机制有助于通过BER-LPHN传递的柏柏林的改善生物可用性.
- 这种新的配方策略有望改善柏林等吸收不良药物的输送和疗效.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
179
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
179
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
162
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
162
Bioavailability Enhancement: Drug Solubility Enhancement
208
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
208
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
186
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
186
Pore Transport and Ion-Pair Transport
1.1K
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
1.1K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.7K


